Cyteir Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CYT research report →
About the company
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing.
- CEO
- Markus F. Renschler
- IPO
- 2021
- Employees
- 46
- HQ
- Lexington, MA, US
Price Chart
- Market Cap
- $108.71M
- P/E
- -2.42
- P/S
- 0.00
- P/B
- 0.73
- EV/EBITDA
- 0.81
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -26.35%
- ROIC
- -32.37%
- Revenue
- $0 · 0.00%
- Net Income
- $-43,952,000 · -5.53%
- EPS
- $-1.25 · -5.93%
- Op Income
- $-48,170,000
- FCF YoY
- -15.11%
- 52W High
- $3.19
- 52W Low
- $1.65
- 50D MA
- $3.09
- 200D MA
- $2.86
- Beta
- 0.10
- Avg Volume
- 167.62K
Get TickerSpark's AI analysis on CYT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 20, 24 | Leonard Braden Michael | buy | 170,589 |
| Mar 18, 24 | Leonard Braden Michael | buy | 113,777 |
| Mar 15, 24 | Leonard Braden Michael | other | 0 |
| Mar 15, 24 | Leonard Braden Michael | other | 0 |
| Mar 4, 24 | Gaiero David G | other | 2,373 |
| Feb 29, 24 | Gaiero David G | other | 4,746 |
| Feb 29, 24 | Gaiero David G | other | 3,239 |
| Feb 29, 24 | Gaiero David G | other | 4,746 |
| Mar 4, 24 | Gaiero David G | other | 2,373 |
| Feb 29, 24 | Gaiero David G | other | 3,239 |
Our CYT coverage
Recent articles, reports, and earnings notes.
No research on CYT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CYT report →Similar companies
Peers in the same neighborhood.